A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2001
10/18/2001	WO2001077225A1 Pressure sensitive adhesive compositions
10/18/2001	WO2001077198A1 Process of microgel synthesis and products produced therefrom
10/18/2001	WO2001077105A1 Dual molecules containing a peroxide derivative, synthesis and therapeutic applications thereof
10/18/2001	WO2001076845A1 Methods of forming shaped articles from suspensions
10/18/2001	WO2001076654A1 Methods and compositions for treating intervertebral disc degeneration
10/18/2001	WO2001076644A2 Lipid-based systems for targeting diagnostic agents
10/18/2001	WO2001076634A1 Oral delivery method and composition for solid medications or dietary supplements
10/18/2001	WO2001076632A1 Formulation for the prevention of cardiovascular disease
10/18/2001	WO2001076631A2 Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia
10/18/2001	WO2001076619A1 Novel use of pulmonary surfactant for the prophylaxis or early treatment of acute pulmonary diseases
10/18/2001	WO2001076610A1 Pharmaceutical composition with a content of calcium or mixture of calcium and vitamin d or mixture of calcium and magnesium in a new formulation
10/18/2001	WO2001076608A1 Compositions for use as penetration promoters in transdermal formulations for highly lipophilic active ingredients
10/18/2001	WO2001076607A1 Dry syrup containing theophylline sustained release microcapsules
10/18/2001	WO2001076604A1 Prophylactic and therapeutic use of oltipraz as an antifibrotic and anticirrhotic agent in the liver and pharmaceutical composition containing oltipraz
10/18/2001	WO2001076601A2 Pharmaceutical compositions comprising salmeterol and ipratropium
10/18/2001	WO2001076597A2 A method of administering an antitumour compound using a polymer-camptothecin conjugate
10/18/2001	WO2001076595A1 Intracorporeal medicaments for high energy phototherapeutic treatment of disease
10/18/2001	WO2001076593A2 Bile secretion promoting composition a 15-keto prostaglandin
10/18/2001	WO2001076582A1 Oil-in-water microemulsions containing tricyclic compounds or preconcentrates thereof
10/18/2001	WO2001076575A2 The treatment of respiratory diseases
10/18/2001	WO2001076567A1 Method and composition for treating cancer by administration of apoptosis-inducing chemotherapeutic agents
10/18/2001	WO2001076566A1 Stable pharmaceutical compositions containing 7-substituted-3,5-dihydroxyheptanoic acids or 7-substituted-3,5-dihydroxyheptenoic acids
10/18/2001	WO2001076565A1 Compositions disintegrating in oral cavity and preparations disintegrating in oral cavity
10/18/2001	WO2001076564A1 Microprojectile delivery system and particulate product
10/18/2001	WO2001076563A1 Method for stabilising particle size distribution of a powdery active principle dispersed in a liquid and uses thereof
10/18/2001	WO2001076562A1 A peroral pharmaceutical formulation for controlled release of a drug
10/18/2001	WO2001076561A2 Pharmaceutical compositions
10/18/2001	WO2001076560A1 Physically stabilized dry powder formulations
10/18/2001	WO2001076558A1 Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix
10/18/2001	WO2001076557A1 Sustained release preparations
10/18/2001	WO2001076556A2 Lipid-based drug delivery systems against parasitic infections
10/18/2001	WO2001076555A2 Lipid-based drug delivery systems for topical application
10/18/2001	WO2001076554A2 Drug delivery composition and device
10/18/2001	WO2001076553A2 Method and device for enhanced transdermal drug delivery
10/18/2001	WO2001076537A1 Treatment of skin damage using polyenylphosphatidylcholine
10/18/2001	WO2001076522A1 Maintaining abstinence after detoxification from opiate addiction
10/18/2001	WO2001076392A1 Odourless garlic supplement comprising an enteric coating and a deodorising layer
10/18/2001	WO2001076381A1 Protein stabilised emulsions
10/18/2001	WO2001076370A2 Anthelmintic combinations
10/18/2001	WO2001036455A3 Chlamydia antigens and corresponding dna fragments and uses thereof
10/18/2001	WO2001035933A3 A method of microencapsulation
10/18/2001	WO2001026683A3 Archaeosomes as adjuvants and carriers for acellular vaccines to induce cytotoxic t lymphocyte (ctl) responses
10/18/2001	WO2001025213B1 Pyrrolo imidazole derivatives and their use as medicaments
10/18/2001	WO2001024817A3 Pharmaceutical compositions of fibrinolytic agent
10/18/2001	WO2000047130A9 Injectable collagen-based system for delivery of cells or therapeutic agents
10/18/2001	WO2000032233A3 Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith
10/18/2001	US20010032014 Stent coating
10/18/2001	US20010031878 Novel processes for making- and a new crystalline form of- leflunomide
10/18/2001	US20010031801 Pumping active agent, polymer, and solvent, form emulsion; forming an emulsion; solvent extraction;
10/18/2001	US20010031787 Minimizing skin damage, irritation or sensitization; nontoxic; used in urogenital disorders
10/18/2001	US20010031784 Antidepressants; simplification
10/18/2001	US20010031779 Methods and materials for treating and preventing inflammation of mucosal tissue
10/18/2001	US20010031773 Administering (5-aryl-1,2,4-thiadiazol)-3-yl thiourea and urea derivatives to treat hepatitis, HIV and Kaposi sarcoma, as viricides and anticarcinogenic agents
10/18/2001	US20010031769 Pharmaceutical compositions
10/18/2001	US20010031761 Compounds such as camptothecin 20-o-nonanoate; antitumor agents; low toxicity; good absorbability
10/18/2001	US20010031755 Novel compositions comprising trimetrexate
10/18/2001	US20010031747 Progestin therapy for maintaining amenorrhea
10/18/2001	US20010031741 Methods for treatment of lysosomal storage diseases
10/18/2001	US20010031740 Mixture containing organic halide
10/18/2001	US20010031737 Unit dosage forms for the treatment of herpes simplex
10/18/2001	US20010031734 Mixture with sugar and, or sugar alcohol
10/18/2001	US20010031725 Polysaccharides
10/18/2001	US20010031497 Complex of chitosan-based compound and a nucleic acid or oligonucleotide; delivers oligonucleotide into cell; non-viral gene delivery
10/18/2001	US20010031282 Dissolving solid in dimethyl ether under pressure; precipitation; separation
10/18/2001	US20010031281 Compositon to enhance permeation of topical skin agents
10/18/2001	US20010031279 Phenoxyethyl substituted 1,2,4-triazolone
10/18/2001	US20010031278 Bioavailability; mixture with carrier
10/18/2001	US20010031277 Water swellable, semipermeable material
10/18/2001	US20010031273 Applying to skins
10/18/2001	US20010031262 Synthetic polymeric carrier; antiallergens
10/18/2001	US20010031251 Polymer
10/18/2001	US20010031244 Mixture of active materials, hydrofluoroalkane propellant and cosolvent
10/18/2001	US20010029959 Nicotine salts having improved taste, process for their preparation and their use
10/18/2001	DE10108042A1 Crystalline citalopram base and salts with high purity useful for treatment of depression
10/18/2001	DE10019171A1 Zusammensetzungen zur Verwendung als Penetrationsverstärker in transdermalen Formulierungen für hoch lipophile Wirkstoffe Compositions for use as penetration enhancers in transdermal formulations for highly lipophilic substances
10/18/2001	DE10016875A1 Stable, skin-compatible cosmetic or dermatological emulsions, comprises hydrophilic ethoxylated emulsifier, hydrophobic emulsifier formed from ethoxylated emulsifiers and stearic acid derivatives, and fatty alcohols
10/18/2001	DE10016559A1 System für den Transport von Aktivstoffen in einem biologischen System System for transporting active substances in a biological system
10/18/2001	DE10016313A1 Orally administered pharmaceutical preparation for retarded drug release in the gastrointestinal tract, comprises gel containing drug in a multiparticulate retard form
10/18/2001	DE10015928A1 Carrier of a medicament or some other active substance administrable via skin comprises a protective layer which is provided with an electric conductor strip running over a separable section of the protective layer
10/18/2001	DE10015907A1 Treatment of inflammation in human beings and animals comprises administration of preparations with a diameter in the nanometer to millimeter range
10/18/2001	DE10015353A1 Recovery of pure terpenes from plants, for use as pharmaceutical or cosmetic active agents, by extracting with solvent at elevated pressure and temperature then cooling and depressurizing to induce crystallization
10/18/2001	CA2409782A1 Drug delivery composition and device
10/18/2001	CA2406484A1 Method and composition for treating cancer by administration of apoptosis-inducing chemotherapeutic agents
10/18/2001	CA2405554A1 Intracorporeal medicaments comprising halogenated xanthenes for high energy phototherapeutic treatment of disease
10/18/2001	CA2405471A1 Method for stabilising particle size distribution of a powdery active principle dispersed in a liquid and uses thereof
10/18/2001	CA2404915A1 Prophylactic and therapeutic use of oltipraz as an antifibrotic and anticirrhotic agent in the liver and pharmaceutical composition containing oltipraz
10/18/2001	CA2404889A1 Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia
10/18/2001	CA2404645A1 Physically stabilized dry powder formulations
10/18/2001	CA2403155A1 Process of microgel synthesis and products produced therefrom
10/18/2001	CA2400740A1 Treatment of skin damage using polyenylphosphatidylcholine
10/18/2001	CA2400386A1 Anthelmintic combinations
10/17/2001	EP1145987A1 Valve for aerosol container
10/17/2001	EP1145719A2 Use a ferrous salt for inhibiting oxidative degradation of pharmaceutical formulations
10/17/2001	EP1145712A1 Sustained release excipient
10/17/2001	EP1145711A1 Flash-melt oral dosage formulation
10/17/2001	EP1145709A1 Use of natural products to prepare cosmetic compositions
10/17/2001	EP1145001A2 (in vitro) model for gastrointestinal inflammation
10/17/2001	EP1144623A1 Method and medicament for inhibiting the expression of a defined gene
10/17/2001	EP1144600A2 Akt-3 nucleic acids, polypeptides, and uses thereof
10/17/2001	EP1144592A2 Substrate for cell growth

1 ... 2352 2353 2354 2355 2356 2357 2358 2359 2360 2361 2362 2363 2364 2365 2366 2367 2368 2369 2370 2371 2372 ... 2991